Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in AVNS / Avanos Medical, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Avanos Medical, Inc. (US:AVNS) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 70,277 shares of Avanos Medical, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F AVANOS MED COM 05350V106 0 -100.00 0
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 70,277 -11,491 -14.05 860 -26.56 0.0017
2025-05-15 2025-03-31 13F AVANOS MED COM 05350V106 81,768 13,768 20.25 1,172 8.23 0.0038
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 68,000 14,906 28.07 1,083 -15.14 0.0033
2024-11-14 2024-09-30 13F AVANOS MED COM 05350V106 53,094 -5,483 -9.36 1,276 9.35 0.0038
2025-02-25 2024-06-30 13F/A-1 AVANOS MED COM 05350V106 58,577 0 0.00 1,167 0.00 0.0035
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 58,577 0 1,167 0.0035
2024-05-15 2024-03-31 13F AVANOS MED COM 05350V106 58,577 58,577 1,166 0.0035
2023-08-14 2023-06-30 13F AVANOS MED COM 05350V106 0 -89,575 -100.00 0 -100.00
2023-05-15 2023-03-31 13F AVANOS MED COM 05350V106 89,575 0 0.00 2,664 9.91 0.0092
2023-02-14 2022-12-31 13F AVANOS MED COM 05350V106 89,575 0 0.00 2,424 24.26 0.0087
2023-02-14 2022-09-30 13F/A-1 Avanos Medical COM 05350V106 89,575 -1,100 -1.21 1,951 -21.34 0.0077
2022-11-14 2022-09-30 13F Avanos Medical COM 05350V106 89,575 -1,100 1,951 0.0077
2023-02-14 2022-06-30 13F/A-1 Avanos Medical COM 05350V106 90,675 -23,525 -20.60 2,479 -35.19 0.0092
2022-08-15 2022-06-30 13F Avanos Medical COM 05350V106 90,675 -23,525 2,480 0.0092
2023-02-14 2022-03-31 13F/A-1 Avanos Medical COM 05350V106 114,200 -3,700 -3.14 3,826 -6.43 0.0109
2022-05-13 2022-03-31 13F Avanos Medical COM 05350V106 114,200 -3,700 3,826 0.0109
2022-02-14 2021-12-31 13F Avanos Medical COM 05350V106 117,900 -12,000 -9.24 4,088 0.86 0.0104
2021-11-15 2021-09-30 13F Avanos Medical COM 05350V106 129,900 0 0.00 4,053 -14.20 0.0114
2021-08-13 2021-06-30 13F/A-1 Avanos Medical COM 05350V106 129,900 100,600 343.34 4,724 268.49 0.0133
2021-08-13 2021-06-30 13F Avanos Medical COM 05350V106 129,900 100,600 4,724 0.0080
2021-05-14 2021-03-31 13F Avanos Medical COM 05350V106 29,300 29,300 1,282 0.0039
2021-02-12 2020-12-31 13F Avanos Medical COM 05350V106 0 -34,636 -100.00 0 -100.00
2021-02-11 2020-09-30 13F/A-1 Avanos Medical COM 05350V106 34,636 -7,264 -17.34 1,151 -6.50 0.0042
2020-11-13 2020-09-30 13F Avanos Medical COM 05350V106 34,636 -7,264 1,151 2,297.5787
2021-02-12 2020-06-30 13F/A-1 AVANOS MED COM 05350V106 41,900 0 0.00 1,231 9.13 0.0048
2020-08-14 2020-06-30 13F AVANOS MED COM 05350V106 41,900 0 1,231 4,854.6281
2021-02-12 2020-03-31 13F/A-2 AVANOS MED COM 05350V106 41,900 4,700 12.63 1,128 -10.05 0.0056
2020-06-15 2020-03-31 13F/A-1 AVANOS MED COM 05350V106 41,900 0 1,128 0.0056
2020-05-15 2020-03-31 13F AVANOS MED COM 05350V106 41,900 4,700 1,128 3,136.9874
2021-02-12 2019-12-31 13F/A-1 AVANOS MED COM 05350V106 37,200 5,000 15.53 1,254 3.98 0.0051
2020-02-18 2019-12-31 13F AVANOS MED COM 05350V106 37,200 5,000 1,254 5,105.8592
2021-02-12 2019-09-30 13F/A-1 AVANOS MED COM 05350V106 32,200 4,900 17.95 1,206 1.26 0.0048
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 32,200 4,900 1,206 4,805.9868
2021-02-12 2019-06-30 13F/A-1 AVANOS MED COM 05350V106 27,300 27,300 1,191 0.0046
2019-08-13 2019-06-30 13F AVANOS MED COM 05350V106 27,300 27,300 1,191 4,670.6011
2018-08-13 2018-06-30 13F HALYARD HEALTH COM 40650V100 0 -34,100 -100.00 0 -100.00
2018-05-14 2018-03-31 13F HALYARD HEALTH COM 40650V100 34,100 -156,300 -82.09 1,571 -82.13 0.0063
2018-02-13 2017-12-31 13F HALYARD HEALTH COM 40650V100 190,400 47,600 33.33 8,793 36.75 0.0345
2017-12-01 2017-09-30 13F/A-1 HALYARD HEALTH COM 40650V100 142,800 3,700 2.66 6,430 17.68 0.0277
2017-11-13 2017-09-30 13F HALYARD HEALTH COM 40650V100 142,800 3,700 6,430
2017-08-10 2017-06-30 13F HALYARD HEALTH COM 40650V100 139,100 73,200 111.08 5,464 117.69 0.0248
2017-05-11 2017-03-31 13F HALYARD HEALTH COM 40650V100 65,900 23,500 55.42 2,510 60.08 0.0113
2017-02-13 2016-12-31 13F HALYARD HEALTH COM 40650V100 42,400 42,400 0.00 1,568 0.0074
2016-11-10 2016-09-30 13F HALYARD HEALTH COM 40650V100 0 -17,360 -100.00 0 -100.00
2016-08-11 2016-06-30 13F HALYARD HEALTH COM 40650V100 17,360 -11,421 -39.68 565 -31.68 0.0025
2016-05-13 2016-03-31 13F HALYARD HEALTH COM 40650V100 28,781 28,781 0.00 827 0.0037
2016-02-12 2015-12-31 13F HALYARD HEALTH COM 40650V100 0 -80,700 -100.00 0 -100.00
2015-11-13 2015-09-30 13F HALYARD HEALTH COM 40650V100 80,700 80,700 0.00 2,295 0.0094
2015-05-13 2015-03-31 13F HALYARD HEALTH COM 40650V100 0 -8,180 -100.00 0 -100.00
2015-02-13 2014-12-31 13F HALYARD HEALTH COM 40650V100 8,180 8,180 372 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.